Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 637 of 6351
-
Could a glaucoma eye drop also heal the cornea?
Disease control CompletedThe goal of this clinical trial is to learn if topical netarsudil/latanoprost works to treat pseudophakic bullous keratopathy in patients with glaucoma. The main questions it aims to answer are: Does topical netarsudil/latanoprost improves visual function in patients with glauco…
Phase 2/3 • Sponsor: University Hospital Dubrava • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
Can cutting arginine from the diet starve solid tumors?
Disease control CompletedThis is a phase I single-arm clinical study conducted by West China Hospital of Sichuan University. The research duration is from March 2025 to March 2027, aiming to evaluate the safety and efficacy of arginine-restricted diet (-Arg diet) in patients with solid tumors. A total of…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 10, 2026 07:00 UTC
-
Could a drug combo save nerves in ear cancer surgery?
Disease control Recruiting nowTo evaluate the efficacy and safety of induction chemotherapy combined with tislelizumab as neoadjuvant therapy in patients with locally advanced squamous cell carcinoma of the external auditory canal; to explore the improvement in the preservation rate of important neurovascular…
Phase 2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a bone marrow injection save young hips after fracture?
Disease control Recruiting nowObjectives: * Primary objective : * To investigate the predisposing factors for femoral neck fractures, including age, sex, and associated comorbidities. * To investigate the complications associated with intracapsular femoral neck fractures, particularly in young patients. * To…
Sponsor: Yaser Alkanash • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for Crohn's sufferers: phase 3 drug trial launches
Disease control Recruiting nowThis Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a weekly shot help type 1 diabetes patients shed pounds and control blood sugar?
Disease control OngoingThe main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New pill shows promise for PNH patients still anemic on standard therapy
Disease control CompletedThe purpose of this study is to evaluate the efficacy of HSK39297 tablets in paroxysmal nocturnal hemoglobinuria (PNH) patients with anemia after stable treatment of anti-C5 antibody.
Phase 3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo aims to turn inoperable stomach cancer into operable disease
Disease control Recruiting nowThis is a prospective, single-center, single-arm, open phase II clinical study. Forty-nine participants with pathologically or cytologically confirmed gastric cancer or gastroesophageal junction cancer are scheduled to be enrolled in this study. All participants will be treated w…
Phase 2 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to tame deadly transplant side effect
Disease control Recruiting nowOptimization of bendamustine-containg graft-versus-host disease (GVHD) prophylaxis to reduce the incidence of secondary haemophagocytic lymphohistiocytosis and GVHD
Phase 2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug IBI362 takes on semaglutide in fatty liver showdown
Disease control OngoingThis is a multicenter, randomized, open-label Phase 3 clinical study comparing the efficacy and safety of IBI362 9 mg QW versus Semaglutide 2.4 mg QW in overweight or obese (BMI≥27kg/m2) MAFLD subjects. Subjects will be randomly assigned to IBI362 9 mg and Semaglutide 2.4 mg grou…
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New nasal spray COVID-19 booster could replace needles
Vaccine Recruiting nowThis Phase I/II trial in France evaluates safety and immunogenicity of a booster dose of an intranasal COVID-19 vaccine (LVT-001) versus a booster dose of a COVID-19 mRNA vaccine (Pfizer-BioNTech) in healthy adult volunteers. As a first-in-human trial, Phase I will assess the sa…
Phase 1/2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC
-
Choice may be key: letting soldiers pick their PTSD therapy could boost success
Disease control Recruiting nowThe purpose of this research study is to learn about how Shared Decision Making, when used to decide treatment, impacts treatment engagement, retention, and outcomes for active duty military personnel seeking treatment for posttraumatic stress disorder (PTSD). Shared Decision Ma…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New ultrasound could rival MRI for prostate cancer detection
Diagnosis Recruiting nowThe purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of …
Phase 3 • Sponsor: University of Alberta • Aim: Diagnosis
Last updated Sep 10, 2026 07:00 UTC
-
New schizophrenia drug aims to ease severe symptoms in hospitalized patients
Symptom relief Recruiting nowThe primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New vaccine aims to shield toddlers from 24 pneumonia strains
Vaccine Recruiting nowA Phase 1b clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 42 days)-23 months. The objective of the study is to evaluate the safety and immunogenicity o…
Phase 1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 09:00 UTC
-
New drug aims to slow kidney damage in IgA nephropathy
Disease control Recruiting nowIn this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). IgAN is a kidney disease caused by the buildup of an antibody called IgA in the kidneys over time. In people with IgAN, abnormal IgA and other antibod…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New buprenorphine start aims to sidestep fentanyl withdrawal
Disease control Recruiting nowThe goal of this clinical trial is to learn if buprenorphine can be started for opioid use disorder with fentanyl use without requiring or precipitating opioid withdrawal. To be eligible, participants must have moderate or severe opioid use disorder and must have fentanyl detecte…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Pee test could revolutionize HIV treatment adherence
Disease control Recruiting nowAntiretroviral therapy (ART) has significantly decreased the morbidity and mortality of HIV infection. However, adherence challenges in taking daily oral ART persist. A retrospective cohort study across 31 countries from 2010-19 reported that only 65% of people with HIV (PWH) on …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Robots may unlock hidden recovery in Stroke-Damaged arms
Symptom relief CompletedIn clinical scenario, clinical scales and kinematic analysis are usually used for the evaluation of patients. However, these methods are limited, since they may suffer from the lack of objectivity and sensitivity. Synergies go beyond pure kinematics and allow to directly understa…
Sponsor: Villa Beretta Rehabilitation Center • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Light-Based imaging may spot High-Risk preeclampsia early
Diagnosis Recruiting nowPreeclampsia is a pregnancy-specific hypertensive disorder and can progress rapidly to severe adverse outcomes affecting both the mother and the fetus. Endothelial and microcirculatory dysfunction mediate systemic preeclampsia-related organ dysfunctions. Changes in endothelial an…
Sponsor: Heidelberg University • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC